Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Friday a net income attributable to common shareholders for the fourth quarter of $27.49 million or $1.18 per share, compared to a net loss of $10.68 million or $0.55 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $2.33 per share, compared to $1.63 per share in the year-ago quarter.
Total net revenues for the quarter grew 29.6 percent to $247.06 million from $190.57 million in the same quarter last year.
Looking ahead to fiscal 2026, the company continues to project adjusted earnings in the range of $8.83 to $9.34 per share on net revenues between $1.055 billion and $1.115 billion.
In Friday's pre-market trading, ANIP is trading on the Nasdaq at $83.00, up $5.85 or 7.58 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.